Guo Jingzhong, Yang Eric C C, Desouza Leroi, Diehl Georg, Rodrigues Mary Joe, Romaschin Alexander D, Colgan Terence J, Siu K W Michael
Department of Chemistry and Centre for Research in Mass Spectrometry, Toronto, Ontario, Canada.
Proteomics. 2005 May;5(7):1953-66. doi: 10.1002/pmic.200401059.
Surface-enhanced laser desorption/ionization-mass spectrometry (SELDI-MS) has conventionally been practiced on linear time of flight (TOF) which has low mass accuracy and resolution. Here we demonstrate in an examination of both malignant and nonmalignant endometrial tissue homogenates that high mass accuracy and resolution in the MS stage are crucial. Using a commercially available quadrupole/TOF (QqTOF), we were able to resolve two potential cancer markers, subsequently identified off-line as chaperonin 10 and calgranulin A, that differ by 8 Da in mass. Two off-line protein identification protocols were developed: the first was based on size-exclusion chromatography (SEC), sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), protein extraction, trypsin digestion, and matrix-assisted laser desorption/ionization-tandem MS (MALDI-MS/MS); the second on SEC and shotgun nano-liquid chromatography (nanoLC)-MS/MS. Analyses on a cohort of 44 endometrial homogenates showed 22 out of 23 nonmalignant samples had nondetectable to very low abundance of chaperonin 10 and calgranulin A; 17 of the 21 malignant samples had detectable to abundant levels of both proteins. Immunohistochemical staining of a tissue microarray of 32 samples showed that approximately half of malignant endometrial tissues exhibited positive staining for calgranulin A in the malignant epithelium, while 9 out of 10 benign tissues exhibited negative epithelial staining. In addition, macrophages/granulocytes in malignant as well as nonmalignant tissues showed positive staining. No immunostaining occurred in stroma or myometrium. Calgranulin A, in combination with chaperonin 10 and other proteins, may eventually constitute a panel of markers to permit diagnosis and screening of endometrial cancer.
表面增强激光解吸/电离质谱法(SELDI-MS)传统上是在质量精度和分辨率较低的线性飞行时间(TOF)上进行的。在此,我们在对恶性和非恶性子宫内膜组织匀浆的检测中证明,质谱阶段的高质量精度和分辨率至关重要。使用市售的四极杆/飞行时间(QqTOF),我们能够分辨出两种潜在的癌症标志物,随后离线鉴定为伴侣蛋白10和钙粒蛋白A,它们的质量相差8道尔顿。开发了两种离线蛋白质鉴定方案:第一种基于尺寸排阻色谱(SEC)、十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)、蛋白质提取、胰蛋白酶消化和基质辅助激光解吸/电离串联质谱(MALDI-MS/MS);第二种基于SEC和鸟枪法纳升级液相色谱(nanoLC)-MS/MS。对44个子宫内膜匀浆的分析表明,23个非恶性样本中有22个检测不到伴侣蛋白10和钙粒蛋白A,或者其丰度极低;21个恶性样本中有17个检测到这两种蛋白,且丰度较高。对32个样本的组织微阵列进行免疫组织化学染色显示,约一半的恶性子宫内膜组织在恶性上皮细胞中钙粒蛋白A呈阳性染色,而10个良性组织中有9个上皮细胞呈阴性染色。此外,恶性和非恶性组织中的巨噬细胞/粒细胞均呈阳性染色。基质或子宫肌层未出现免疫染色。钙粒蛋白A与伴侣蛋白10及其他蛋白质结合,最终可能构成一组标志物,用于子宫内膜癌的诊断和筛查。